1.725

3.63% -0.065

After Hours: 1.72 -0.005 -0.29%

Organogenesis Holdings Inc (ORGO)

Overview News Price History Option Chain Financials Discussions Forecast

Organogenesis Holdings Inc stock is traded at $1.725, with a volume of 585.98K. It is down -3.63% in the last 24 hours and down -34.16% over the past month. Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Previous Close:

$1.79

Open:

$1.77

24h Volume:

585.98K

Relative Volume:

0.64

Market Cap:

$221.96M

Revenue:

$514.70M

Net Income/Loss:

$2.72M

P/E Ratio:

-10.86

EPS:

-0.1589

Net Cash Flow:

$17.08M

1W Performance:

-7.26%

1M Performance:

-34.16%

6M Performance:

-53.88%

1Y Performance:

-63.53%

1-Day Range:

$1.70

$1.77

1-Week Range:

$1.70

$1.9343

52-Week Range:

$1.54

$7.0771

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Name

Organogenesis Holdings Inc

Sector

Healthcare (1089)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

781-575-0775

Address

85 DAN ROAD, CANTON, MA

Employee

854

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

ORGO's Discussions on Twitter

Compare ORGO vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ORGO Organogenesis Holdings Inc	1.725	230.33M	514.70M	2.72M	17.08M	-0.1589
TAK Takeda Pharmaceutical Co Adr	17.38	56.30B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.47	42.85B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.585	42.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	72.97	30.49B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	508.33	21.43B	3.17B	1.29B	1.01B	27.09

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-28-24	Initiated	Lake Street	Buy
Feb-07-24	Initiated	Cantor Fitzgerald	Overweight
Jun-15-23	Initiated	Morgan Stanley	Equal-Weight
May-24-23	Upgrade	BTIG Research	Neutral → Buy
Nov-10-22	Downgrade	BTIG Research	Buy → Neutral
Aug-10-22	Downgrade	Oppenheimer	Outperform → Perform
Jan-10-20	Initiated	SVB Leerink	Outperform
Aug-26-19	Resumed	Credit Suisse	Outperform
May-02-19	Initiated	Credit Suisse	Outperform
Apr-17-19	Initiated	Oppenheimer	Outperform
Apr-11-19	Initiated	SunTrust	Buy

View All

Organogenesis Holdings Inc Stock (ORGO) Latest News

Aug 13, 2026

Organogenesis (ORGO) Q2 2026 Earnings Call Transcript - AOL.com

Aug 13, 2026

Organogenesis, lured to RI with tax credits, is bleeding money - The Business Journals

Aug 13, 2026

Aug 11, 2026

OrganiGram: Fiscal Q3 Earnings Snapshot - AOL.com

Aug 11, 2026

Aug 10, 2026

Organogenesis Holdings, Inc. Class A Revenue Breakdown – MUN:2PQ - TradingView

Aug 10, 2026

Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution - Yahoo Finance

Aug 10, 2026

Aug 08, 2026